International Scholarly Research Notices / 2012 / Article / Tab 3 / Clinical Study
Impact of Dual Antiplatelet Therapy with Proton Pump Inhibitors on the Outcome of Patients with Acute Coronary Syndrome Undergoing Drug-Eluting Stent Implantation Table 3 Univariate analysis for re-ACS event.
Patients with re-ACS (
𝑛
=
4
5
)
𝑃
value < 0.05Patients without re-ACS (
𝑛
=
1
3
1
) Age 66.8 ± 10.45 0.055 63.46 ± 9.85 Male
𝑛
(%) 37 (82.22) 0.846 108 (82.24) Smoke 16 (35.55) 0.97 45 (0.34) Dyslipidemia 21 (46.66) 0.25 76 (58.01) Familiar history 14 (31.11) 0.562 49 (37.40) Hypertension 33 (73.33) 0.918 97 (74.04) Obesity (
B
M
I
>
3
0
Kg/m2 ) 1 (2.22) 0.03 21 (16.03) Diabetes 27 (60) 0.022 51 (38.93) Renal failure 9 (20) 0.92 29 (22.13) Anemia
𝑛
(%) 18 (40) 0.55 44 (33.58) Multivessel disease n (%) 15 (33.33) 0.756 49 (37.40) No. Stents 1.24 ± 0.60 0.918 1.25 ± 0.55 Omeprazole 22 (48.88) 0.0019 30 (22.90) Esomeprazole 8 (17.77) 0.012 6 (4.58) Lansoprazole 5 (11.11) 0.43 8 (6.10) Pantoprazole 3 (6.66) 0.0033 39 (29.77) Anti-H2 7 (15.55) 0.0144 48 (36.64)
